FMC's first global dossier for rimisoxafen seeks U.S. approval for a dual-action herbicide aimed at tough broadleaf weeds in major crops.
FMC secures a $400 million investment from Tessenderlo Group to cut debt, strengthen liquidity and support crop protection technology growth.
FMC plans a $114M Newark property sale to cut debt, retain key R&D operations and keep its Stine Research Center fully intact.
| Financial Services Industry | Financials Sector | Pierre R. Brondeau CEO | XMEX Exchange | US3024913036 ISIN |
| US Country | 5,500 Employees | 16 Jul 2026 Last Dividend | 4 Mar 2019 Last Split | 1 Jul 1985 IPO Date |
FMC Corporation stands as a notable entity in the agricultural sciences sector, focusing on crafting innovative solutions to protect crops and enhance plant health. This multifaceted company boasts an extensive portfolio of products and services tailored for both agricultural and non-agricultural needs, ranging from pest and turf management to crop protection. Its efforts are centered on increasing crop yield and quality through the management of insects, weeds, and diseases. Founded in 1883 with its headquarters in Philadelphia, Pennsylvania, FMC Corporation has expanded its footprint globally, operating across North America, Latin America, Europe, the Middle East, Africa, and Asia. The company showcases its global reach and commitment to agriculture and pest control by utilizing a comprehensive marketing network made up of its own sales organization, alliance partners, independent distributors, and sales representatives.
FMC Corporation's robust product lineup and services are engineered to meet both the rigorous demands of modern agriculture and the specialized needs of non-agricultural pest control. The company's offerings can be categorized into the following: